Molecular characteristics of carbaryl, a CYP1A1 gene inducer

被引:16
|
作者
Sandoz, C
Lesca, P
Narbonne, JF
Carpy, A
机构
[1] Univ Bordeaux 1, CNRS, UMR 5472, Lab Phys & Toxicochim Syst Nat, F-33405 Talence, France
[2] INRA, Lab Pharmacotoxicol, F-31931 Toulouse, France
关键词
carbaryl; CYP1A1; gene; aryl hydrocarbon receptor; structure; conformation; lipophilicity;
D O I
10.1006/abbi.1999.1515
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Carbaryl belongs to a series of compounds that activate the CYP1A1 gene. This study demonstrates the inability of carbaryl to compete with 2,3,7,8-tetrachlorodibenzo-p-dioxin for binding to the rat aryl hydrocarbon (dioxin) receptor, Structural and physicochemical properties of this insecticide, in relation to the requirements for binding to the aryl hydrocarbon receptor, are described. The crystal structure was determined experimentally using X-ray diffraction. A conformational search using molecular mechanics was performed by means of a Monte-Carlo-type method and a stochastic dynamics simulation. Lipophilicity calculations, log P, and molecular lipophilicity potential are also presented. Common and discriminating properties of carbaryl and aryl hydrocarbon receptor ligands are discussed, (C) 2000 academic Press.
引用
收藏
页码:275 / 280
页数:6
相关论文
共 50 条
  • [1] PICROTOXIN IS A CYP1A1 INDUCER IN RAINBOW-TROUT HEPATOCYTES
    SADAR, MD
    ASH, R
    ANDERSSON, TB
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 214 (03) : 1060 - 1066
  • [2] THE CYP1A1 GENE AND CANCER SUSCEPTIBILITY
    KAWAJIRI, K
    NAKACHI, K
    IMAI, K
    WATANABE, J
    HAYASHI, S
    CRITICAL REVIEWS IN ONCOLOGY/HEMATOLOGY, 1993, 14 (01) : 77 - 87
  • [3] Role of CYP1A1 MspI polymorphism in CYP1A1 gene with susceptibility to lung cancer in Iranian patients
    Motovali-Bashi, Majid
    Biglari, Mostafa
    Hojati, Zohreh
    Hemati, Simin
    Khodadad, Kian
    JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2012, 17 : S243 - S247
  • [4] Expression of the human CYP1A1 gene in mice
    Beaton, D
    Nguyen, N
    Galijatovic, A
    Bonzo, J
    Tukey, RH
    FASEB JOURNAL, 2004, 18 (08): : C86 - C86
  • [5] DETECTION OF CYP1A1 GENE POLYMORPHISM USING DESIGNED RFLP AND DISTRIBUTIONS OF CYP1A1 GENOTYPES IN JAPANESE
    OYAMA, T
    MITSUDOMI, T
    KAWAMOTO, T
    OGAMI, A
    OSAKI, T
    KODAMA, Y
    YASUMOTO, K
    INTERNATIONAL ARCHIVES OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH, 1995, 67 (04) : 253 - 256
  • [6] The transcriptional activation of the CYP1A1 gene by LXRα
    Shibahara, Norihito
    Masunaga, Yuiko
    Iwano, Shunsuke
    Kamataki, Tetsuya
    DRUG METABOLISM REVIEWS, 2006, 38 : 49 - 49
  • [7] OMEPRAZOLE, AN INDUCER OF HUMAN CYP1A1 AND 1A2, IS NOT A LIGAND FOR THE AH RECEPTOR
    DAUJAT, M
    PERYT, B
    LESCA, P
    FOURTANIER, G
    DOMERGUE, J
    MAUREL, P
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 188 (02) : 820 - 825
  • [8] MicroRNA changes associated with atypical CYP1A1 inducer BMS-764459
    Simic, Damir
    Euler, Cathy
    Haines, Emily
    He, Aiqing
    Peden, W. Mike
    Bunch, R. Todd
    Sanderson, Thomas
    Van Vleet, Terry
    TOXICOLOGY, 2013, 311 (03) : 169 - 177
  • [9] CYP1A1 gene polymorphism and polycystic ovary syndrome
    Esinler, Ibrahim
    Aktas, Dilek
    Otegen, Umit
    Alikasifoglu, Mehmet
    Yarali, Hakan
    Tuncbilek, Ergul
    REPRODUCTIVE BIOMEDICINE ONLINE, 2008, 16 (03) : 356 - 360
  • [10] CYP1A1 gene variant, vascular disease and diabetes
    Wang, J
    Greco, M
    Sim, AS
    Duarte, N
    Wilcken, DEL
    Wang, XL
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2001, 21 (04) : 680 - 680